Director of Pharmacy Department, Shi Ying, Invited to Attend the 2025 Hong Kong Pharmacy Conference
Innovation Convergence, Leading Transformation, and Building a New Era of Pharmacy Together
[February 22-23, 2025, Hong Kong] Dr. Shi Ying, Director of the Pharmacy Department at Shenzhen New Frontier United Family Hospital, was invited to attend the 2025 Hong Kong Pharmacy Conference. Themed “Innovation Convergence, Leading Transformation, and Building a New Era of Pharmacy,” the conference focused on the innovative developments and collaborative prospects of the pharmaceutical field in the Guangdong-Hong Kong-Macao Greater Bay Area. At the event, Dr. Shi shared valuable insights into Shenzhen New Frontier United Family Hospital’s experiences in clinical pharmacy services, innovative drug utilization, and cross-border medical innovations, providing attendees with a comprehensive regional perspective.
The annual conference aimed to explore the latest advancements and trends in the pharmacy sector, facilitate knowledge-sharing on valuable initiatives, and strengthen collaborations within the Greater Bay Area’s pharmaceutical landscape. Throughout the event, distinguished scholars, industry experts, and professionals from Guangdong, Hong Kong, and Macao gathered to discuss the future development and cooperation opportunities in the pharmacy industry.
Shenzhen New Frontier United Family Hospital: Advancing Clinical Pharmacy Services
During her presentation, Dr. Shi highlighted that Shenzhen New Frontier United Family Hospital, as a comprehensive medical institution within the Greater Bay Area, has been dedicated to improving the quality and efficiency of clinical pharmacy services. The hospital’s highly skilled and professional pharmacy team ensures medication safety and efficacy by conducting prior review of all prescriptions, providing medication information, and offering pharmaceutical consultations. Additionally, the hospital is committed to continuously enhancing the overall patient medical experience to deliver superior healthcare services.
Innovation in Drug Utilization and Cross-Border Medical Advancements
Shenzhen New Frontier United Family Hospital has actively responded to policy directives by introducing clinically urgent and already-approved innovative drugs from Hong Kong and Macao. Dr. Shi shared a notable breakthrough in cross-border medical innovation—the successful introduction of Ruxolitinib Cream, the world’s first FDA-approved topical treatment for vitiligo. This milestone not only signifies the hospital’s pioneering efforts in cross-border medical services and innovative drug access but also reinforces its leading position in the field of medical innovation.
Industry Recognition and Future Collaborations
Dr. Shi’s presentation garnered significant attention and sparked in-depth discussions among conference attendees. Participants widely acknowledged that enhancing clinical pharmacy services and nurturing young pharmacists is critical to the development of the pharmacy profession. The practices and explorations of Shenzhen New Frontier United Family Hospital in clinical pharmacy, innovative drug utilization, and cross-border medical cooperation offer valuable references and inspiration for advancing pharmacy collaboration in the Greater Bay Area.
Furthermore, Dr. Shi emphasized that Shenzhen New Frontier United Family Hospital will continue to strengthen partnerships with institutions such as the CUHK-Shenzhen Medical School, fostering pharmaceutical research and talent development. The hospital plans to engage in more specialty exchanges between Shenzhen and Hong Kong medical institutions, promoting cross-border collaborations in clinical services and research initiatives to further contribute to the pharmaceutical industry in the Greater Bay Area and beyond.
The 2025 Hong Kong Pharmacy Conference provided an invaluable platform for experts and industry leaders to exchange insights and foster collaborations. Dr. Shi Ying’s presentation not only showcased Shenzhen New Frontier United Family Hospital’s achievements and expertise in pharmacy innovation but also offered profound perspectives for attendees. Looking ahead, the pharmacy sector in the Greater Bay Area is set to achieve remarkable progress through collective efforts and continuous advancements.
